documents: FDA-2024-D-4540-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2024-D-4540-0001 FDA FDA-2024-D-4540 Recommended Followup Testing for an Ames-Positive Drug (Active Ingredient) or Metabolite To Support First-in-Human Clinical Trials With Healthy Subjects; Draft Guidance for Industry; Availability Notice Notice of Availability 2024-11-27T05:00:00Z 2024 11 2024-11-27T05:00:00Z   2024-11-27T15:40:10Z 2024-27796 0 0 090000648683a82d

Links from other tables